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Abstract
Summary This study investigated the association between mild cognitive impairment (MCI) and physical function and bone
health in older adults. MCI was associated with poor physical performance but not bone mineral density or bone
microarchitecture.
Purpose Cross-sectional study to investigate the association between mild cognitive impairment (MCI) and physical perfor-
mance, and bone health, in a community-dwelling cohort of older adults.
Methods Cognitive function of 222 men and 221 women (mean age 75.5 and 75.8 years in men and women, respectively) was
assessed by the Strawbridge questionnaire and Mini Mental State Exam (MMSE). Participants underwent dual-energy X-ray
absorptiometry (DXA), peripheral-quantitative computed tomography (pQCT) and high-resolution peripheral-quantitative com-
puted tomography (HR-pQCT) scans to assess their bone density, strength and microarchitecture. Their physical function was
assessed and a physical performance (PP) score was recorded.
Results In the study, 11.8% of women and 8.1% of men were cognitively impaired on the MMSE (score < 24). On the
Strawbridge questionnaire, 24% of women were deemed cognitively impaired compared to 22.3% of men. Cognitive impairment
on the Strawbridge questionnaire was associated with poorer physical performance score in men but not in women in the
unadjusted analysis. MMSE < 24 was strongly associated with the risk of low physical performance in men (OR 12.9, 95%
CI 1.67, 99.8, p = 0.01). Higher MMSE score was associated with better physical performance in both sexes. Poorer cognitive
function, whether assessed by the Strawbridge questionnaire, or by MMSE score, was not associated with bone density, shape or
microarchitecture, in either sex.
Conclusion MCI in older adults was associated with poor physical performance, but not bone density, shape or microarchitecture.
Keywords Mild cognitive impairment . Physical performance . Bone parameters . Epidemiology
Introduction
Mild cognitive impairment (MCI) is a heterogeneous state
between normal ageing and early dementia [1]. The preva-
lence of MCI is rising as the population ages. It has been
estimated to affect 19% of individuals aged 65 and over [2].
While cognitive decline is a well-documented clinical hall-
mark of MCI, changes in physical health are also apparent
during the course of MCI and include increased physical fra-
gility and reduced physical performance [3–6], resulting in
individuals being at increased risk of injuries [7].
Emerging data suggest bone mineral density (BMD) is re-
duced in severely cognitively impaired individuals, compared
to cognitively normal individuals of a similar age [8].
Although it has been suggested that there may be a link
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between cognitive impairment and BMD [9], little is known
about bone loss rates in MCI subjects.
The majority of evidence to date has been derived from
studies set in long-term care/nursing homes and hospitals [7,
10–12] where individuals are frail and severely cognitively
impaired. The purpose of this study was to further investigate
whether an association exists between MCI and both bone
health and physical performance status in a well-established
community-dwelling cohort of older adults. If MCI was asso-
ciated with reduced bone density, this might be considered an
important risk factor for fracture that could be addressed in
treatment algorithms that included anti-osteoporosis therapy.
Methods
The Hertfordshire Cohort Study (HCS) is a population-based
UK cohort of older adults. Study design and recruitment have
been described in detail previously [13]. In brief, we traced
men and women born between 1931 and 1939 in
Hertfordshire and who still lived there in 1998–2003. A
nurse-administered questionnaire, which included details of
socioeconomic status and dietary calcium intake, was con-
ducted at this time. In 2011–2012, 443 participants consented
to a home visit by a trained research nurse. At this visit, a
nurse-administered questionnaire was again administered
which included details of smoking status, alcohol consump-
tion and physical activity (average minutes per day spent
walking, cycling, gardening, playing sport and doing house-
work in the last 2 weeks). Height was measured to the nearest
0.1 cm and weight to the nearest 0.1 kg on a SECA floor scale
(Chasmors Ltd., London, UK). Body mass index (BMI) was
calculated as weight divided by square of height (kg/m2).
All assessments detailed below were performed in
2011/2012.
Cognitive function assessment
Participants completed a Mini Mental State Examination
(MMSE) [14] and Strawbridge questionnaire. The
Strawbridge questionnaire consisted of 16 questions assessing
four functional domains: physical, nutritive, cognitive and
sensory. The cognitive domain of the questionnaire was
scored positive when difficulty was reported often or very
often for paying attention, finding the right word, remember-
ing things or remembering where something was put [15].
Physical performance assessment
Hand grip strength was measured using a Jamar handheld
dynamometer [16]. Participants undertook three physical
performance tasks: (1) gait speed [17], (2) repetitive sit-to-
stand [18] and (3) modified Tinetti balance test [19]. A phys-
ical performance score was scored according to Guralnik et al.
[20]. Participants were given scores of 0 to 4, with best per-
formance scoring 4. The scores for three physical performance
tasks were then summed. The maximum possible score was
12 and the minimum was 0. In keeping with previous work
[20], those with a score equal to or lower than 9 were deemed
as having low physical performance.
Dual-energy X-ray absorptiometry (DXA)
A DXA scan was performed to measure BMC (g) and aBMD
(g/cm2) at the non-dominant hip using a Lunar Prodigy
Advanced Scanner, UK. Positioning for all scans was com-
pleted in accordance with the manufacturer’s instructions. The
effective dose to the subject during each scan was 0.009 μSv.
Peripheral quantitative computed
tomography (pQCT)
Distal radial and tibial pQCTscans were performed on the non-
dominant side except when it had previously fractured (Stratec
2000 instrument, voxel size 80 μm). A scout view was per-
formed on the lower leg to place a reference from which mea-
surement sites are determined. Two slices were taken in the
radial scan (4 and 66%). Four slices were taken for the lower
leg scan (4, 14, 38 and 66%). Measurements were taken from
both the radius and tibia total bone areas (TBAs), trabecular
bone mineral density (tBMD), cortical bone mineral density
(cBMD) and cortical bone area (cBA). Short-term measure-
ment precision error was expressed as a coefficient of variation,
ranged from 0.88% (total tibial density, 4% slice) to 8.8% (total
radial area, 66% slice), but was typically between 1 and 3%.
These figures were obtained using images acquired from 20
volunteers who were part of the study and hence were repre-
sentative of the study population. The effective dose to the
subject during each scan was 0.01 μSv.
High-resolution peripheral quantitative
tomography (HR-pQCT)
Each participant hadmeasurements of the non-dominant distal
radius and distal tibia using HR-pQCT (XtremeCT, Scanco
Medical AG, Switzerland) except when it had previously been
fractured in which case the dominant side was scanned. A total
of 110 slices were obtained which represented a volume of
bone 9 mm in axial length with a nominal resolution (voxel
size) of 82 μm. Antero-posterior 2D scout views were per-
formed to determine the region to be scanned. All scans were
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performed in keeping with the manufacturer’s guidelines and
as described by Boutroy et al. [21].
Image analysis was carried out using the standard manu-
facturer’s method which has been described in detail previ-
ously [22]. Analysis produced the following outcomes: total
BMD (Tt.vBMD, g/cm3), trabecular BMD (Tb.vBMD,
g/cm3), trabecular number (Tb.N, per mm), trabecular thick-
ness (Tb.Th, μm), trabecular separation (Tb.Sp, μm), cortical
area (Ct.area, mm2), cortical density (Ct.vBMD, g/cm3), cor-
tical porosity (Ct.Po, %) and cortical thickness (Ct.Th, μm).
Short-term precision values for cortical and trabecular BMD
have been shown to range from 0.3 to 1.2 [23]. The effective
dose to the subject during each scan was < 3 μSv.
Ethical permission
Ethical permission for the study was granted by the East and
North Hertfordshire Ethical Committees. All participants gave
written informed consent.
Exclusion criteria
Study participants who were taking drugs that are known to
alter bone metabolism (e.g. bisphosphonates) were excluded
from the study. However, women who were taking hormone
replacement therapy (HRT) were allowed to participate.
Statistical analysis
Variables were assessed for normality and transformed
where necessary using the Fisher-Yates rank-based inverse
normal transformation to create z-scores (FY z-scores).
Descriptive statistics for continuous variables were
expressed as mean and standard deviation (SD) or median
and interquartile range (IQR). Categorical variables were
expressed as frequency and percentage (%). Differences
between men and women were assessed using Student’s t
tests, Mann-Whitney tests or Pearson’s χ2 tests, as appro-
priate. Linear and logistic regression analyses were used to
examine the associations between being cognitively frail
on the Strawbridge Cognitive Domain and MMSE score
and physical performance, and bone outcomes. The regres-
sion analyses were undertaken with and without adjust-
ment for the following lifestyle confounders: age, BMI,
social class, smoker status, alcohol consumption, physical
activity and dietary calcium intake, and, in women only,
years since menopause and HRT use. Statistical analyses
were performed using STATA, version 14.
Results
Study participants and characteristics
The characteristics of the study participants are displayed in
Table 1. The mean (SD) age of participants was 75.5 (2.5) and
75.8 (2.6) years in men and women, respectively. On average,
men were taller (p < 0.001) and heavier (p < 0.001) than wom-
en but BMI did not differ significantly by sex.
MMSE and Strawbridge questionnaire assessments
The median (IQR) MMSE score was 28 (25–29) for both men
and women. In the study, 11.8% of women were cognitively
impaired on the MMSE (score < 24), compared to 8.1% of
men. On the Strawbridge questionnaire, 24% of women were
deemed cognitively impaired compared to 22.3% of men.
Associations between cognitive impairment
and physical performance outcomes
Men had a greater mean maximum grip strength compared
to women, 36.1 and 21.3 kg, respectively (p < 0.001). Gait
speed was faster in men than in women: 0.78 vs 0.73 m/s
(p = 0.006). The median time for the repetitive sit-to-stand
test in men (15.8 s, IQR 13.6–18.8) was less than that for
women (17.0 s, IQR 13.8–20.2), p = 0.05. Fifty-six
(26.3%) women were unable to perform the Tinetti balance
test for greater than 10 s, compared to 43 (20.1%) men (p =
0.13). One hundred and forty-one women (71.2%) had a
physical performance score of 9 or less, compared to 116
men (56.9%) (p = 0.003).
Table 2 shows the associations between being cognitively
impaired as defined by the Strawbridge questionnaire and
physical performance outcomes in men and women.
Cognitive impairment on the Strawbridge questionnaire
was associated with poorer physical performance score in
men but not in women in the unadjusted analysis. In women,
cognitive impairment on the Strawbridge questionnaire was
associated with a weaker grip strength; however, statistical
significant was lost when confounders were adjusted for.
Table 3 shows the associations between MMSE score (and
MMSE score < 24) and physical performance outcomes in
men and women.
In women, MMSE score was associated with gait speed,
physical performance score and higher prevalence of low
physical performance score (≤ 9) following adjustments for
confounders. As in men, MMSE score was associated with
physical performance score. However, following adjust-
ment for confounders, this association became non-signif-
icant. In men, MMSE score < 24 was associated with
poorer gait speed, repetitive sit-to-stand, modified Tinetti
balance test and physical performance score. In men,
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MMSE < 24 was strongly associated with the risk of low
physical performance (OR 12.9, 95% CI 1.67, 99.8, p =
0.01), although we were unable to run adjusted models due
to low numbers.
Associations between cognitive impairment on bone
parameters
Bone mineral content (BMC) and bone mineral density
(BMD) were higher in men than in women at both hip and
spine (data not shown). Male mean radial (4 and 66% slices)
and tibial (4, 14, 38 and 66% slices) bone parameters as
assessed by pQCT and HRpQCT scans were significantly
greater than those in females (p < 0.001). Few statistically sig-
nificant relationships were found between DXA, pQCT or
HRpQCT outcomes and either cognitive frailty, as assessed
by the Strawbridge questionnaire, or MMSE score in both
men and women (unadjusted and adjusted, data not shown).
Discussion
In this study, we utilised the Strawbridge cognitive domain
and MMSE to investigate the potential association between
cognitive impairment and both physical performance status,
and bone mineral density and architecture in a community-
dwelling cohort of elderly adults. We have shown MCI is
associated with poor physical performance, but not bone den-
sity or microarchitecture in this cohort. It is recognised that
physical performance decline is one of the most important
predictors of future adverse health consequences such as dis-
ability, institutionalisation, hospitalisation and need for home
healthcare assistance [24]. Thus, given the findings of this
study, and the magnitude and speed of population ageing,
identification of individuals with MCI is an important health
priority.
Decreasing physical activity (PA) or maintaining a persis-
tent physically inactive lifestyle is associated with greater de-
cline in physical performance [25]. Furthermore, studies have
Table 1 Baseline characteristics of study participants
Descriptives Men Women p value
Characteristics N Mean SD N Mean SD
Age (years) 222 75.5 2.5 221 75.8 2.6 0.280
Height (cm) 221 172.7 6.5 217 158.8 6.1 < 0.001
Weight (kg) 221 82.2 1.2 221 70.2 1.2 < 0.001
BMI (kg/m2) 221 27.9 3.9 217 28.4 5.1 0.252
N Median IQR N Median IQR p value
Activity time in last 2 weeks (min/day) 205 176.4 105.0–270.0 210 199.6 135.0–282.9 0.089
Daily dietary calcium intake (mg) 222 1221 1021–1432 221 1105 939–1281 < 0.001
Alcohol consumption (units per week) 222 6.5 1.0–14.0 221 0.5 0.0–3.5 < 0.001
Total N N % Total N N % p value
Smoker status 222 221 < 0.001
Never 85 38.3 142 64.3
Ex 126 56.8 73 33.0
Current 11 5.0 6 2.7
Social class 211 221 0.520
I–IIINM 89 42.2 100 45.2
IIIM–V 122 57.8 121 54.8
Years since menopause 218
< 20 years 23 10.6
≥ 20 to < 25 years 53 24.3
≥ 25 to < 30 years 45 20.6
≥ 30 to < 35 years 24 11.0
≥ 35 11 5.0
Hysterectomy 62 28.4
HRT use 213
Never 116 54.5
5 years or more ago 91 42.7
Current 6 2.8
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demonstrated regular PA is a protective factor against cogni-
tive impairment in the elderly, particularly women [26, 27].
Severely cognitively impaired individuals demonstrate signif-
icant reductions in levels of habitual physical activity [28]. It
is possible that cognition-related behaviour changes may ex-
acerbate age-related bone loss. In this study, we have demon-
strated that MCI is associated with poorer physical perfor-
mance. This decline in physical performance may lead to re-
duction in habitual physical activity and potentially lead to
immobility, resulting in BMD loss over time. This process is
likely to be exacerbated as further cognition-related behav-
iours develop as the degree of cognitive decline increases.
In this study, we demonstrated no association betweenMCI
and bone mineral density, size or microarchitecture at the hip,
radius or tibia. However, a previous study [29] has demon-
strated that bone mineral architecture is reduced in individuals
with severe cognitive impairment and Alzheimer’s disease
(AD). These results suggest that BMD loss might be directly
proportional to the degree of cognitive impairment. A possible
explanation is that cognitive-related neurodegenerative brain
changes may directly affect central control of bone remodel-
ling. Atrophy of the limbic system, including the hypothala-
mus, increases with the degree of cognitive impairment and is
a prominent hallmark of AD [30]. The hypothalamus regu-
lates homeostatic metabolic processes, including the major
role of regulating bone mass. Therefore, we may be able to
account for our findings by proposing that individuals with
MCI do not possess the amount of atrophy within the hypo-
thalamus to affect regulation of bone mass, thus preserving
their BMD. However, as further neurodegeneration occurs
within the limbic system, the imbalance in bone remodelling
homeostasis is impaired resulting in greater bone turnover and
bone mineral loss, as seen in AD. Further studies assessing
brain atrophy, including the limbic system, to examine the
hypothesis that neurodegeneration may contribute to loss of
bone mass are required.
Longitudinal studies of the relationship between cognitive
function and physical performance in subsets of patients have
suggested a link. In 177 UK patients with moderate to severe
cognitive impairment (MMSE 11–23) followed up for a 1-year
period, many neuropsychological, physical and functional per-
formance measures declined [31]. Baseline gait speed was sig-
nificantly associated with decline in verbal function, while
controlling for age, education, dementia drug use and baseline
cognitive performance [31]. In other works, in a US-
randomised controlled trial of daily engagement of meaningful
activity in adults of mean age 71 years with mild cognitive
impairment, change in self-rated performance predicted
change in depressive symptoms, suggesting that targeting
physical performance in this group is worthwhile [32]. In an-
other randomised controlled trial of cognitive and physical
activity in 308 older Japanese adults with mild cognitive im-
pairment [33], compared with the control group, the combinedTa
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activity group showed significantly greater scores on the
MMSE. Finally, malnutrition must be considered as a possible
contributing factor in the development of sarcopenia or
presarcopenia in adults with MCI; this can be targeted in inter-
ventions as appropriate [34]. These findings suggest not only a
link betweenMCI and physical performance, but that interven-
tion is feasible and beneficial in a range of populations.
Much of the available literature reporting associations be-
tween cognitive impairment and physical performance have
been performed in Asian populations [35–40]. Decreased
physical performance, as assessed by the short performance
battery test, was associated with subsequent cognitive decline
in 298 subjects ofmean age 72 years at baseline [35] and a high
prevalence of sarcopenia (> 20%) was recognised in Japanese
subjects attending a memory loss clinic [36]. Reduced muscle
strength and function was demonstrated in a Taiwanese popu-
lation where the prevalence of sarcopenia was 7% [37] while
sarcopenia was significantly associated with cognitive impair-
ment and depressive symptoms among otherwise healthy older
men living in a Taiwanese veterans retirement community
[38]. While in another study that considered relationships be-
tweenmetabolic and atherosclerotic disease with outcomes in a
Chinese population, cognitive impairment, high waist-hip ra-
tio, diabetes, stroke and heart disease were all independently
associated with higher physical frailty with adjustment for age,
physical activity level and appendicular skeletal muscle mass
[39]. In a final study of Chinese older adults > 65 years, the
cognitively impaired group had weaker grip strength and per-
formed worse in the physical function tests [40]. In rare
European data, among some 1600 UK men enrolled in the
British Regional Heart Study, compared with participants in
the normal cognitive ageing group, participants with signifi-
cant cognitive impairment were more likely to have a BMI >
30 and to be sarcopenic [41].
One of the limitations of this study is the lack of a
standardised diagnostic tool for MCI. Therefore, by using the
Strawbridge questionnaire and MMSE, we may have under-/
overestimatedMCI in our cohort. Additionally, our analyses are
cross-sectional, and longitudinal data are now needed. Finally,
appreciation that the Strawbridge questionnaire provides a sub-
jective measure of cognitive impairment must be made. By
contrast, one of the study’s strengths is the study population.
The individuals recruited were a non-selective community-
dwelling population who were born in Hertfordshire and con-
tinued to live there at the age of 60–75 years. HCS characteristic
and mortality patterns have previously been demonstrated to be
similar to those of England [42], thus generalisation to thewider
population of older adults can be made. Using standardised
batteries for physical performance tests and bone mineral archi-
tecture analysis which have well-known predictive ability for
adverse health outcomes in older adults was another strength.
Longitudinal studies objectively assessing the full spectrum of
cognitive impairment within a community-dwelling population
would be beneficial to confirm our results. Additionally, it may
identify which stage of cognitive impairment is associated with
increased falls and reduction in bone mineral architecture.
Conclusions
This study suggests mild cognitive impairment in elderly
community-dwelling adults is associated with poor physical
performance especially in men but not altered bone density or
microarchitecture.
Acknowledgements We thank all of the men and women who took part
in the Hertfordshire Cohort Study; the Hertfordshire Cohort Study
Research Staff; and Vanessa Cox who managed the data.
Funding information The Hertfordshire Cohort Study was supported by
the Medical Research Council of Great Britain, Arthritis Research UK
and the International Osteoporosis Foundation.
Compliance with ethical standards
Conflict of interest Professor C Cooper has received consultancy fees/
honoraria from Servier; Eli Lilly; Merck; Amgen; Alliance; Novartis;
Medtronic; GSK; Roche.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Lopez OL,Kuller LH, Becker JT, Dulberg C, Sweet RA, Gach HM,
DeKosky ST (2007) Incidence of dementia in mild cognitive im-
pairment in the cardiovascular health study cognition study. Arch
Neurol 64(3):416–420
2. Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green
RC, Hayden K, Norton MC, Zandi PP, Toone L,West NA, Breitner
JCS, the Cache County Investigators (2006) Conversion to demen-
tia from mild cognitive disorder—the Cache County study.
Neurology 67(2):229–234
3. Burns JM,CronkBB,AndersonHS,Donnelly JE, ThomasGP,Harsha
A, Brooks WM, Swerdlow RH (2008) Cardiorespiratory fitness and
brain atrophy in early Alzheimer disease. Neurology 71:210–216
4. Camarda R, Camarda C, Monastero R, Grimaldi S, Camarda LK,
Pipia C, Caltagirone C, GangitanoV (2007)Movements executions
in amnestic mild cognitive impairment and Alzheimer’s disease.
Behav Neurol 18:135–142
5. Kluger A, Gianutsos JG, Golomb J, Ferris SH, Reisberg B (1997)
Motor/psychomotor dysfunction in normal aging, mild cognitive
decline, and early Alzheimer’s disease: diagnostic and differential
features. Int J Psychogeriatr 9:307–316
6. Barrett-Connor E, Edelstein S, Corey-Bloom J, Wiederholt W
(1998) Weight loss precedes dementia in community-dwelling
older adults. J Nutr Health Aging 2:113–114
Arch Osteoporos  (2018) 13:44 Page 7 of 8  44 
7. Douglas A, Letts L, Richardson J (2011) A systematic review of
accidental injury for older adults with and without dementia. Arch
Gerontol Geriatr 52:1–10
8. Sato Y, Honda Y, Hayashida N, Iwamoto J, Kanoko T, Satoh K
(2005) Vitamin K deficiency and osteopenia in elderly women with
Alzheimer’s disease. Arch Phys Med Rehabil 86:576–581
9. Dudek M, Pietraszkiewicz F, Drozdzowska B (2008) Alzheimer’s dis-
ease and osteoporosis: common risk factors or one condition predis-
posing to the other? J Orthopaedics, Trauma Rehabil 10:315–323
10. Harlein J, Halfen RJG, Dassen T, Lahmann NA (2011) Falls in
older hospital inpatients and the effects of cognitive impairment: a
secondary analysis of prevalence studies. J Clin Nurs 20:175–183
11. van Doorn C, Gruber-Baldini AL, Zimmerman S, Hebel JR, Port
CL, Baumgarten M, Quinn CC, Taler G, May C, Magaziner J;
Epidemiology of Dementia in Nursing Homes Research Group.
Dementia as a risk factor for falls and fall injuries among nursing
home residents. J Am Geriatr Soc. 2003 Sep;51(9):1213–8
12. Rudolph JL, Zanon NM, Jones RN, Marcantionio ER, Fong TG,
Yang FM (2010) Hospitalisation in community-dwelling persons
with Alzheimer’s: frequency and causes. J Am Geriatr Soc 58:
1542–1548
13. Dennison EM, Syddall HE, Aihie Sayer A, Gilbody HJ, Cooper C
(2005) Birth weight and weight at 1 year are independent determi-
nants of bone mass in the seventh decade: the Hertfordshire cohort
study. Paediatr Res 57:582–586
14. Folstein M, Folstein S, McHugh P (1975) Mini-mental state. J
Psychol Res 12:189–198
15. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA
(1998) Antecedents of frailty over three decades in an older cohort.
J Gerontol Series B, Psychol Sci Soc Sci 53:S9–S16
16. BohannonRW (1986) Test-retest reliability of hand held dynamom-
etry during a single session of strength assessment. Phys Ther 66:
206–209
17. Posiadlo D, Richardson S (1991) The timed Bup and go^: a test of
basic functional mobility for frail elderly persons. J Am Geriatr Soc
39:142–148
18. Csuka M, McCarty DJ (1985) Simple method for measurement of
lower extremity muscle strength. Am J Med 78:77–78
19. Tinetti ME (1986) Performance oriented assessment of mobility
problems in the elderly patient. Am Geiatr Soc 34:119–126
20. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF,
Blazer DG et al (1994) A short physical performance battery
assessing lower extremity function: association with self-reported
disability and prediction of mortality and nursing home admission.
J Gerontol 2:M85–M94
21. Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo
assessment of trabecular bone microarchitecture by high-
resolution peripheral quantitative computed tomography. J Clin
Endocrinol Metab 90:6508–6515
22. Laib A, Hauselmann HJ, Ruegsegger P (1998) In vivo high resolu-
tion 3D-QCT of the human forearm. Technol Health Care 6(5–6):
329–337
23. Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK (2010)
Reproducibility of direct quantitative measures of cortical bone
microarchitecture of the distal radius and tibia by HRpQCT. Bone
47:519–528
24. Guralnik JM, Simonsick EM, Ferrucci L (1995) Lower extremity
function in persons over the age of 70 years as a predictor of sub-
sequent disability. N Engl J Med 332:556–561
25. Stenholm S, Koster A, Valkeinen H (2016) Association of physical
activity history with physical function and mortality in old age. J
Am Geriatr Soc 71:496–501
26. Pareja-Galeno H, Garatachea N, Lucia A (2015) Exercise as a
polypill for chronic diseases. Program Mol Biol Transl Sci 135:
497–526
27. de Labra C, Guimaraes-Pinheio C, Maseda A, Lorenzo T, Millan-
Calenti JL (2015) Effects of physical exercise interventions in frail
older adults: a systematic review of randomised controlled trials.
BMC Geriatr 15:154
28. Ensrud KE, Lui LY, Paudel ML, Schousboe JT, Kats AM, Cauley
JA, McCulloch CE, Yaffe K, Cathon PM, Hillier TA, Taylor BC
(2017) Effects of mobility and cognition on hospitalisation and
inpatient days in women in late life. J Gerontol 22:82–88
29. Loskutova N, Honea RA, Vidoni E, Brooks WM, Burns JM (2009)
Bone density and brain atrophy in early Alzheimer’s disease. J
Alzheimers Dis 4:777–785
30. Whitwell JL, Petersen RC, Negash S, Weigand SD, Kantarci K,
Ivnik RJ, Knopman DS, Boeve BF, Smith GE, Jack CR Jr (2007)
Patterns of atrophy differ among specific subtypes of mild cognitive
impairment. Arch Neurol 64(8):1130–1138
31. Taylor ME, Lasschuit DA, Lord SR, Delbaere K, Kurrle SE,
Mikolaizak AS, Kvelde T, Close JCT (2017) Slow gait speed is
associated with executive function decline in older people with
mild to moderate dementia: a one year longitudinal study. Arch
Gerontol Geriatr 73:148–153
32. Ellis JL, Altenburger P, Lu Y (2017) Change in depression, confi-
dence, and physical function among older adults with mild cogni-
tive impairment. J Geriatr Phys Ther:1
33. Shimada H, Makizako H, Doi T, Park H, Tsutsumimoto K,
Verghese J, Suzuki T (2017) Effects of combined physical and
cognitive exercises on cognition and mobility in patients with mild
cognitive impairment: a randomized clinical trial. J Am Med Dir
Assoc
34. Tay L, Leung BP, Wee S, Tay KS, Ali N, Chan M, Lim WS (2017)
Association of nutrition and immune-endocrine dysfunction with
muscle mass and performance in cognitively impaired older adults.
Arch Gerontol Geriatr 75:20–27
35. Moon JH, Moon JH, Kim KM, Choi SH, Lim S, Park KS, Kim
KW, Jang HC (2016) Sarcopenia as a predictor of future cognitive
impairment in older adults. J Nutr Health Aging 20(5):496–502
36. Sugimoto T, Ono R, Murata S, Saji N, Matsui Y, Niida S, Toba K,
Sakurai T (2016) Prevalence and associated factors of sarcopenia in
elderly subjects with amnestic mild cognitive impairment or
Alzheimer disease. Curr Alzheimer Res 13(6):718–726
37. Huang CY, Hwang AC, Liu LK, Lee WJ, Chen LY, Peng LN, Lin
MH, Chen LK (2016) Association of dynapenia, sarcopenia, and
cognitive impairment among community-dwelling older
Taiwanese. Rejuvenation Res 19(1):71–78
38. Hsu YH, Liang CK, ChouMY, LiaoMC, LinYT, Chen LK, LoYK
(2014) Association of cognitive impairment, depressive symptoms
and sarcopenia among healthy older men in the veterans retirement
community in southern Taiwan: a cross-sectional study. Geriatr
Gerontol Int 14(Suppl 1):102–108
39. Lee JS, Auyeung TW, Leung J, Kwok T, Leung PC, Woo J (2011)
Physical frailty in older adults is associated with metabolic and
atherosclerotic risk factors and cognitive impairment independent
of muscle mass. J Nutr Health Aging 15(10):857–862
40. Auyeung TW, Kwok T, Lee J, Leung PC, Leung J, Woo J (2008)
Functional decline in cognitive impairment—the relationship be-
tween physical and cognitive function. Neuroepidemiology 31(3):
167–173
41. Papachristou E, Ramsay SE, Lennon LT, Papacosta O, Iliffe S,
Whincup PH, Wannamethee SG (2015) The relationships between
body composition characteristics and cognitive functioning in a
population-based sample of older British men. BMCGeriatr 15:172
42. Dennison EM, Syddall HE, Aihie Sayer A, Gilbody HJ, Cooper C
(2005) Birth weight, infant weight gain and cause-specific mortal-
ity: the Hertfordshire cohort study. Am J Epidemiol 161:1074–1780
 44 Page 8 of 8 Arch Osteoporos  (2018) 13:44 
